Equazen

Equazen is a specialized consumer healthcare brand focused on the development and commercialization of lipid-based nutritional supplements. The company's core product line, also named Equazen, consists of specific ratios of omega-3 and omega-6 fatty acids designed to support neurological health and cognitive function. Originally founded in the United Kingdom, Equazen gained international recognition for its clinical research into the effects of fatty acids on neurodevelopmental conditions such as ADHD and dyspraxia. In 2006, the company was acquired by Galenica (which later became Vifor Pharma) and is currently part of the CSL group. Equazen products are widely distributed globally and are frequently recommended by healthcare professionals for pediatric cognitive support.